SELENON - C-terminal region Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-SELENON - C-terminal region antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | SELENON - C-terminal region |
| Clone | polyclonal |
| Host Species | Rabbit |
| Reactive Species | cow, guinea pig, horse, human, mouse, rat |
| Isotype | n/a |
| Format | affinity purified |
| Size | 0.1 mL |
| Concentration | n/a |
| Applications | Western Blot (WB), Immunohistochemistry (IHC) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | This is a rabbit polyclonal antibody against Sepn1. It was validated on Western BlotTarget Description: This gene encodes a glycoprotein that is localized in the endoplasmic reticulum. It plays an important role in cell protection against oxidative stress, and in the regulation of redox-related calcium homeostasis. Mutations in the orthologous gene in human are associated with early onset muscle disorders, referred to as SEPN1-related myopathy. Knockout mice deleted for this gene exhibit abnormal lung development. This protein is a selenoprotein, containing the rare amino acid selenocysteine (Sec). Sec is encoded by the UGA codon, which normally signals translation termination. The 3' UTRs of selenoprotein mRNAs contain a conse |
| Immunogen | Immunogen: The immunogen is a synthetic peptide corresponding to a region of Mouse |
| Other Names | [selenoprotein N; selenoprotein N; selenoprotein N] |
| Gene, Accession # | [SELENON], Gene ID: 74777, NCBI: NP_083376, UniProt: D3Z5N3 |
| Catalog # | MBS3208689 |
| Price | $335 |
| Order / More Info | SELENON - C-terminal region Antibody from MYBIOSOURCE INC. |
| Product Specific References | n/a |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies